Quantum blue anti-adalimumab: development and evaluation of a point of care rapid test for measuring anti-adalimumab antibodies in human serum

被引：0
|
作者：
Ricken, B. [1 ]
Schneider, M. [1 ]
Bantleon, F. [1 ]
Velayutham, S. [1 ]
Trapani, D. [1 ]
Afonso, J. [2 ]
Magro, F. [2 ]
Abel, A. [1 ]
机构：
[1] BUHLMANN Labs AG, Schoenenbuch, Switzerland
[2] Univ Porto, Fac Med, Dept Biomed, Unit Pharmacol & Therapeut, Porto, Portugal
来源：
JOURNAL OF CROHNS & COLITIS | 2019年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P153
引用
收藏
页码：S166 / S166
页数：1
相关论文
共 50 条
  • [21] Clinical utility of newly developed immunoassays for serum concentrations of adalimumab and anti-adalimumab antibodies in patients with Crohn’s disease
    Hirotsugu Imaeda
    Kenichiro Takahashi
    Takehide Fujimoto
    Shigeki Bamba
    Tomoyuki Tsujikawa
    Masaya Sasaki
    Yoshihide Fujiyama
    Akira Andoh
    [J]. Journal of Gastroenterology, 2014, 49 : 100 - 109
  • [22] The influence of anti-adalimumab antibodies on adalimumab trough levels, TNF-α levels and clinical outcome
    Bodini, G.
    Savarino, V.
    Dulbecco, P.
    Baldissarro, I.
    Savarino, E.
    [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 : S42 - S42
  • [23] THE INFLUENCE OF ANTI-ADALIMUMAB ANTIBODIES ON ADALIMUMAB THROUGH LEVELS, TNF-α LEVELS AND CLINICAL OUTCOME
    Bodini, G.
    Savarino, V.
    Dulbecco, P.
    Baldissarro, I.
    Savarino, E.
    [J]. DIGESTIVE AND LIVER DISEASE, 2015, 47 : E94 - E95
  • [24] Comparison of a new rapid method for determination of serum anti-adalimumab and anti-infliximab antibodies with two established ELISA kits
    Laserna-Mendieta, Emilio J.
    Salvador-Martin, Sara
    Marin-Jimenez, Ignacio
    Menchen, Luis A.
    Lopez-Cauce, Beatriz
    Lopez-Fernandez, Luis A.
    Lucendo, Alfredo J.
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2021, 198
  • [25] A case of Crohn’s disease that developed anti-infliximab and anti-adalimumab antibodies
    Takahashi K.
    Fujimoto T.
    Shioya M.
    Nishida A.
    Bamba S.
    Inatomi O.
    Imaeda H.
    Kitoh K.
    Andoh A.
    [J]. Clinical Journal of Gastroenterology, 2015, 8 (2) : 88 - 91
  • [26] ELISA VS. HMSA: A COMPARISON BETWEEN TWO DIFFERENT METHODS FOR MEASURING ADALIMUMAB SERUM CONCENTRATION AND ANTI-ADALIMUMAB ANTIBODIES PRELIMINARY DATA
    Bodini, G.
    Savarino, V.
    Dulbecco, P.
    Baldissarro, I.
    Savarino, E. V.
    [J]. DIGESTIVE AND LIVER DISEASE, 2014, 46 : S67 - S67
  • [27] Therapeutic drug monitoring of adalimumab in RA: no predictive value of adalimumab serum levels and anti-adalimumab antibodies for prediction of response to the next bDMARD
    Ulijn, Evy
    den Broeder, Nathan
    Wientjes, Maike
    van Herwaarden, Noortje
    Meek, Inger
    Tweehuysen, Lieke
    van der Maas, Aatke
    van den Bemt, Bart J. F.
    den Broeder, Alfons A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (07) : 867 - 873
  • [28] Anti-adalimumab antibodies in psoriasis: lack of clinical utility and laboratory evidence
    Lombardi, G.
    Perego, S.
    Sansoni, V.
    Diani, M.
    Banfi, G.
    Altomare, G.
    [J]. BMJ OPEN, 2016, 6 (12):
  • [29] QUANTUM BLUE® ADALIMUMAB: EVALUATION OF A POINT OF CARE RAPID TEST FOR THERAPEUTIC DRUG MONITORING OF SERUM ADALIMUMAB LEVELS
    Bantleon, F. I.
    Krauchi, S.
    Schuster, T. B.
    Schneider, M.
    Weber, J. M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1463 - 1464
  • [30] Clinical utility of newly developed immunoassays for serum concentrations of adalimumab and anti-adalimumab antibodies in patients with Crohn's disease
    Imaeda, Hirotsugu
    Takahashi, Kenichiro
    Fujimoto, Takehide
    Bamba, Shigeki
    Tsujikawa, Tomoyuki
    Sasaki, Masaya
    Fujiyama, Yoshihide
    Andoh, Akira
    [J]. JOURNAL OF GASTROENTEROLOGY, 2014, 49 (01) : 100 - 109
12345